Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens

Virchows Arch. 2021 Aug;479(2):295-304. doi: 10.1007/s00428-021-03055-z. Epub 2021 Feb 16.

Abstract

Autoantibodies against islet cell antigens are routinely used to identify subjects at increased risk of symptomatic type 1 diabetes, but their relation to the intra-islet pathogenetic process that leads to positivity for these markers is poorly understood. We screened 556 non-diabetic organ donors (3 months to 24 years) for five different autoantibodies and found positivity in 27 subjects, 25 single- and two double autoantibody-positive donors. Histopathological screening of pancreatic tissue samples showed lesion characteristic for recent-onset type 1 diabetes in the two organ donors with a high-risk profile, due to their positivity for multiple autoantibodies and HLA-inferred risk. Inflammatory infiltrates (insulitis) were found in a small fraction of islets (<5%) and consisted predominantly of CD3+CD8+ T-cells. Islets with insulitis were found in close proximity to islets devoid of insulin-positivity; such pseudo-atrophic islets were present in multiple small foci scattered throughout the pancreatic tissue or were found to be distributed with a lobular pattern. Relative beta cell area in both single and multiple autoantibody-positive donors was comparable to that in autoantibody-negative controls. In conclusion, in organ donors under age 25 years, insulitis and pseudo-atrophic islets were restricted to multiple autoantibody-positive individuals allegedly at high risk of developing symptomatic type 1 diabetes, in line with reports in older age groups. These observations may give further insight into the early pathogenetic events that may culminate in clinically overt disease.

Keywords: Autoantibodies; Beta cells; HLA class I; HLA-DQ; Insulitis; Islets; Type 1 diabetes.

MeSH terms

  • Adolescent
  • Age Factors
  • Antigens / immunology*
  • Autoantibodies / blood*
  • Biomarkers / blood
  • CD8-Positive T-Lymphocytes / immunology*
  • Case-Control Studies
  • Cell Proliferation
  • Child
  • Child, Preschool
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / immunology*
  • Diabetes Mellitus, Type 1 / pathology
  • Donor Selection
  • Female
  • Humans
  • Infant
  • Insulin-Secreting Cells / immunology*
  • Insulin-Secreting Cells / pathology
  • Islets of Langerhans Transplantation*
  • Male
  • Tissue Donors*
  • Young Adult

Substances

  • Antigens
  • Autoantibodies
  • Biomarkers